Recruiting Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma NCT07332507 Conditions Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more Locations City of Hope Comprehensive Cancer Center LAO — Duarte, California, United States View Trial Details
